Rating History for Summit Therapeutics plc (SMMT) by H.C. Wainwright

Date Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
5/22/2026 Mitchell S. Kapoor Downgrade Neutral
(Buy)
N/A
(N/A)
17.47
(14.28)
-18.26% Details